Correlation Between Stenocare and Orphazyme

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Stenocare and Orphazyme at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stenocare and Orphazyme into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stenocare AS and Orphazyme AS, you can compare the effects of market volatilities on Stenocare and Orphazyme and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stenocare with a short position of Orphazyme. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stenocare and Orphazyme.

Diversification Opportunities for Stenocare and Orphazyme

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Stenocare and Orphazyme is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Stenocare AS and Orphazyme AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orphazyme AS and Stenocare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stenocare AS are associated (or correlated) with Orphazyme. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orphazyme AS has no effect on the direction of Stenocare i.e., Stenocare and Orphazyme go up and down completely randomly.

Pair Corralation between Stenocare and Orphazyme

Assuming the 90 days trading horizon Stenocare AS is expected to generate 3.89 times more return on investment than Orphazyme. However, Stenocare is 3.89 times more volatile than Orphazyme AS. It trades about 0.16 of its potential returns per unit of risk. Orphazyme AS is currently generating about -0.2 per unit of risk. If you would invest  157.00  in Stenocare AS on August 28, 2024 and sell it today you would earn a total of  55.00  from holding Stenocare AS or generate 35.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Stenocare AS  vs.  Orphazyme AS

 Performance 
       Timeline  
Stenocare AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Stenocare AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Stenocare is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Orphazyme AS 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Orphazyme AS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Orphazyme is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Stenocare and Orphazyme Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Stenocare and Orphazyme

The main advantage of trading using opposite Stenocare and Orphazyme positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stenocare position performs unexpectedly, Orphazyme can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orphazyme will offset losses from the drop in Orphazyme's long position.
The idea behind Stenocare AS and Orphazyme AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Transaction History
View history of all your transactions and understand their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios